Vascular smooth muscle cells in intimal hyperplasia, an update
S Déglise, C Bechelli, F Allagnat - Frontiers in physiology, 2023 - frontiersin.org
Arterial occlusive disease is the leading cause of death in Western countries. Core
contemporary therapies for this disease include angioplasties, stents, endarterectomies and …
contemporary therapies for this disease include angioplasties, stents, endarterectomies and …
[HTML][HTML] Targeting smooth muscle cell phenotypic switching in vascular disease
Objective The phenotypic plasticity of vascular smooth muscle cells (VSMCs) is central to
vessel growth and remodeling, but also contributes to cardiovascular pathologies. New …
vessel growth and remodeling, but also contributes to cardiovascular pathologies. New …
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
Background Despite the use of aspirin, there is still a risk of ischaemic events after
percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to …
percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to …
Optical projection tomography as a tool for 3D microscopy and gene expression studies
Current techniques for three-dimensional (3D) optical microscopy (deconvolution, confocal
microscopy, and optical coherence tomography) generate 3D data by “optically sectioning” …
microscopy, and optical coherence tomography) generate 3D data by “optically sectioning” …
Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
S Silber, P Albertsson, FF Avilés… - European heart …, 2005 - academic.oup.com
In patients with stable CAD, PCI can be considered a valuable initial mode of
revascularization in all patients with objective large ischaemia in the presence of almost …
revascularization in all patients with objective large ischaemia in the presence of almost …
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2
Thromboxane (Tx) A2 is a vasoconstrictor and platelet agonist. Aspirin affords
cardioprotection through inhibition of TxA2 formation by platelet cyclooxygenase (COX-1) …
cardioprotection through inhibition of TxA2 formation by platelet cyclooxygenase (COX-1) …
Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases
TE Van Dyke, CN Serhan - Journal of dental research, 2003 - journals.sagepub.com
The periodontal diseases are infectious diseases caused by predominantly Gram-negative
bacteria. However, as our understanding of the pathogenesis of the periodontal diseases …
bacteria. However, as our understanding of the pathogenesis of the periodontal diseases …
Clinical aspects of platelet inhibitors and thrombus formation
TA Meadows, DL Bhatt - Circulation research, 2007 - Am Heart Assoc
The platelet, once thought to be solely involved in clot formation, is now known to be a key
mediator in various others processes such as inflammation, thrombosis, and atherosclerosis …
mediator in various others processes such as inflammation, thrombosis, and atherosclerosis …
Macrophage differentiation to foam cells
P Shashkin, B Dragulev, K Ley - Current pharmaceutical design, 2005 - ingentaconnect.com
Foam cell formation from macrophages with subsequent fatty streak formation plays a key
role in early atherogenesis. Foam cell formation is thought to be induced by Low Density …
role in early atherogenesis. Foam cell formation is thought to be induced by Low Density …
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
MG Bousser, P Amarenco, A Chamorro, M Fisher… - The Lancet, 2011 - thelancet.com
Background Patients with ischaemic stroke or transient ischaemic attack (TIA) are at high
risk of recurrent stroke or other cardiovascular events. We compared the selective …
risk of recurrent stroke or other cardiovascular events. We compared the selective …